Lujan, Scott A.
Longley, Matthew J.
Humble, Margaret H.
Lavender, Christopher A.
Burkholder, Adam
Blakely, Emma L.
Alston, Charlotte L.
Gorman, Grainne S.
Turnbull, Doug M.
McFarland, Robert
Taylor, Robert W.
Kunkel, Thomas A.
Copeland, William C. http://orcid.org/0000-0002-0359-0953
Funding for this research was provided by:
National Institute of Environmental Health Sciences (ES065078, ES065080, ES065070)
Wellcome Trust Centre for Mitochondrial Research (203105/Z/16/Z)
Medical Research Council International Centre for Genomic Medicine in Neuromuscular Disease
Mitochondrial Disease Patient Cohort (G0800674)
NIHR Newcastle Biomedical Research Centre
Lily Foundation
UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children
NIHR postdoctoral fellowship (PDF-2018-11-ST2-02)
Article History
Received: 7 April 2020
Accepted: 7 August 2020
First Online: 17 September 2020
Ethics approval and consent to participate
: This study was approved and performed under the ethical guidelines issued by the Newcastle and North Tyneside Local Research Ethics Committees (reference 09/H0906/75) and complied with the Declaration of Helsinki.
: The authors claim no competing interests. The views expressed in this publication are those of the author(s) and not necessarily those of the NIH, NIEHS, NHS, the National Institute for Health Research, or the Department of Health and Social Care.